News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


First NZ patient to receive breakthrough heart device

Media Information

First New Zealand patient to receive breakthrough heart device

World’s first implantable cardioverter defibrillator suitable for fullbody MRI scan

What: Clinicians based at Tauranga Hospital are amongst the first international experts to implant breakthrough technology which helps to prevent sudden cardiac death in those at risk, without denying access to fullbody MRI scanning in the future. The Medtronic Evera MRI system is the first device which detects and treats dangerously high heart rates (tachycardia)and also allows fullbody MRI scanning under certain conditions. .

Implantable cardioverter defibrillators (ICD) have played an important role in preventing sudden cardiac arrest, however until now, patients with devices have been unable to receive full body MRI scans because of potential interactions between the MRI and device function. These patients have relied on CT scans or xrays which can fail to detect the same level of detail for conditions including tumours, muscle damage, and other internal injuries.

It is estimated that as many as 63 percent of ICD patients will need an MRI within 10 years of receiving a device.[i] The heart of a person in tachycardia can pump between 100 to 400 beats per minute. At these elevated rates, the heart is not able to efficiently pump oxygenrich blood to the body, causing shortness of breath, chest pain, lightheadedness or loss of consciousness. In severe cases, it can cause heart attack or death, which is known as Sudden Cardiac Arrest (SCA).[ii] Each year, an estimated 4,000 New Zealanders will experience SCA with only 8 percent (320 people) surviving the event. Defibrillation is the only definitive treatment for SCA, and survival decreases 710 percent for every minute without it.[iii] Sudden cardiac arrest can affect anyone; however detection is possible through appropriate screening including longterm cardiac monitoring.

In brief: Tauranga Hospital is the first facility in New Zealand to implant the breakthrough technology compatible with fullbody MRI scanning which detects and delivers therapy for patients at risk of sudden cardiac arrest (SCA).

Each year 4,000 New Zealanders experience an SCA event with only an 8 percent survival rate. SCA risk can be detected through appropriate screening and once detected clinicians will generally recommend implantable cardioverter defibrillator (ICD) therapy consistent with the treatment guidelines by the Cardiac Society of New Zealand.

What this means to patients: Each year, only 8 percent of the estimated 4,000 New Zealanders who experience a sudden cardiac arrest (SCA) survive. For those who do, the likelihood of experiencing a future SCA is six times greater than the general population. Implantable Cardioverter Defibrillator (ICD) therapy has been in used in New Zealand to prevent SCA for more than 15 years.

It is estimated that as many as 63 percent of ICD patients will need an MRI within 10 years of receiving a device.[iv] Because no ICD system has yet been approved for MRConditional use, patients with devices have been contraindicated from receiving MRI scans due to the potential interactions between the MRI and the ICD.

About the technology: Compared to other ICDs available, the Evera MRI system gives patients the most unrestricted access to MRI scans, and ultimately allows them to get the diagnostic answers they need. The device is paired with the Sprint Quattro® Secure family of ICD leads, which has 10 years of performance data with active monitoring[v] and can be used in an MRI environment.[vi] The system provides clinicians and patients with increased longevity, improved comfort, and fullbody MRI access.

MRI scans allow physicians to make a wide range of health diagnoses by viewing highly detailed images of internal organs, blood vessels, muscle, joints, tumours, and areas of infection. MRI utilises strong magnetic fields and radio frequency pulses to create images of structures inside the body.

Implantable cardioverter defibrillator (ICD) therapy is used to treat tachycardia (a heart rate that is too fast). An ICD continuously monitors the heart. If a dangerous and potentially lifethreatening heart rate is detected, a painless electrical signal is sent to correct it. If the electrical signal fails to convert the arrhythmia, a shock is delivered to correct the potentially lethal rhythm. In addition to the device, one or more leads (tiny insulated wire) are implanted to carry information signals from the heart to the ICD and when necessary, to carry electrical impulses to the heart.

About Tachycardia/Sudden cardiac arrest: Tachycardia is the term for a fast heart rate, more than 100 beats per minute and as many as 400 beats per minute. At these elevated rates, the heart is not able to efficiently pump oxygenrich blood to the body, causing shortness of breath, chest pain, lightheadedness or loss of consciousness. In severe cases, it can cause heart attack or death, which is known as Sudden Cardiac Arrest (SCA).[vii] Tachycardia can occur in either the upper or lower heart chambers. Causes of tachycardia include, but aren’t limited to, heart related conditions such as hypertension (highblood pressure), poor blood supply to the heart muscle due to coronary artery disease, heart failure, heart muscle disease, tumours or infections.viii

#Ends

i Turakhia M, Reynolds M, Wolff S, et al. Medtronic Data on File 2013. Data from 2011 MarketScan® Commercial and Medicare database, Truven Analysis, Inc. were used for this research. Patient cohort represents ICD patients in terms of age, gender, and major comorbidities (N = 10,778).


ii http://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_300290.pdf Accessed 24 Jan 2013

iii American Heart Association. AHA Scientific Position – Sudden Cardiac Death. Available at http://www.americanheart.org/presenter.jhtml?identifier=4741.


iv Turakhia M, Reynolds M, Wolff S, et al. Medtronic Data on File 2013. Data from 2011 MarketScan® Commercial and Medicare database, Truven Analysis, Inc. were used for this research. Patient cohort represents ICD patients in terms of age, gender, and major comorbidities (N = 10,778).


v Medtronic Product Performance Report, 2012 Second Edition, Issue 66.


vi Models 6935M (55cm, 62cm) and 6947M (55cm, 62cm)

vii http://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_300290.pdf Accessed 24 Jan 2013

viiihttp://www.medtronic.com.au/your-health/tachycardia/index.htm Accessed 24 Jan 2013

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Review: The Magic Flute - Magic Moments

Max Rashbrooke: Mozart’s The Magic Flute is an extraordinary tale, blending a story of great solemnity, of elegant music and Masonic virtue overcoming hatred and discord, with elements of extreme silliness and pure fantasy. .. More>>

ALSO:

Scoop Review Of Books: ‘Lovely Swans Of Art’

On Cillia McQueen's 'In a Slant Light': Diary-keeping forms the basis of much of this memoir – as with earlier poems – and we are led gracefully through the waves of her life as she sails through both rough and smooth waters. More>>

Scoop Review Of Books: From Here And There

Being Chinese: A New Zealander’s Story
by Helene Wong.
This is the fascinating story of Helene Wong, born in 1949 in Taihape to Chinese parents: her mother, born soon after her parents migrated here, and her father, born in China but sent to relatives in Taihape at seven to get an education in English. More>>

Chiku: Hamilton Zoo's Baby Chimpanzee Named

Hamilton Zoo has named its three-month-old baby chimpanzee after a month-long public naming competition through the popular zoo’s website. The name chosen is Chiku, a Swahili name for girls meaning "talker" or "one who chatters". More>>

Game Over: Trans-Tasman Netball League To Discontinue

Netball Australia and Netball New Zealand have confirmed that the existing ANZ Championship format will discontinue after the current 2016 season, with both organisations to form national netball leagues in their respective countries. More>>

NZSO Review: Stephen Hough Is Perfection-Plus

He took risks, and leant into the music when required. But you also felt that every moment of his playing made sense in the wider picture of the piece. Playing alongside him, the NZSO were wonderful as ever, and their guest conductor, Gustavo Gimeno, coaxed from them a slightly darker, edgier sound than I’m used to hearing. More>>

ALSO:

Howard Davis Review: King Lear At Circa

In order to celebrate it's 40th birthday, it is perhaps fitting that Circa Theatre should pick a production of 'King Lear,' since it's also somewhat fortuitously Shakespeare's 400th anniversary. If some of the more cerebral poetry is lost in Michael Hurst's streamlined, full throttle production, it's more than made up for by plenty of lascivious violence designed to entertain the groundlings. More>>

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news